BRKR - ブルカ― (Bruker Corporation) ブルカ―

 BRKRのチャート


 BRKRの企業情報

symbol BRKR
会社名 Bruker Corp (ブルカ―)
分野(sector) Capital Goods   資本財(工業製品)
産業(industry) Biotechnology: Laboratory Analytical Instruments  
業種 先端医療機器_テクノロジ―   医療関連(Health Care)
概要 事業概要 ブルカー(Bruker Corporation)は生命科学、製薬、バイオテクノロジー、臨床と分子診断研究、及び様々な産業と政府用途での材料および化学分析分野における多様な顧客層の急速に変化するニーズに対応する科学機器のグローバルなメーカー。同社の技術プラットフォームは磁気共鳴技術、質量分析技術、ガスクロマトグラフィー技術、X線技術、スパーク発光分光分析法、原子間力顕微鏡法、スタイラス及び光学的測定技術、並びに赤外線とラマン分子分光法技術を含む。同社は化学・生物・放射性物質・核・爆発物(CBRNE)探知用の一連のフィールド分析システムを製造・販売する。平成24年4月、同社はSkyScan N.V.を買収した。   ブルカ―は、米国の生命科学関連の分析装置メ―カ―。最先端科学の研究に取り組む企業や研究機関へMRI(生体用核磁気共鳴装置)、EPR(電子常磁性共鳴装置)、X線回折装置・分析装置、ナノ表面分析システム、質量分析装置、赤外分光計・その周辺機器などを販売し、アフタ―サ―ビスを提供する。  Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with its customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology.
本社所在地 40 Manning Road Billerica MA 01821 USA
代表者氏名 Frank H. Laukien フランクH.ローキン
代表者役職名 Chairman of the Board President Chief Executive Officer 取締役会長兼最高経営責任者(CEO)
電話番号 +1 978-663-3660
設立年月日 33270
市場名 NASDAQ National Market System
ipoyear ―年
従業員数 6200人
url www.bruker.com
nasdaq_url https://www.nasdaq.com/symbol/brkr
adr_tso
EBITDA EBITDA(百万ドル) 313.30000
終値(lastsale) 33.24
時価総額(marketcap) 5196102727.2
時価総額 時価総額(百万ドル) 4914.725
売上高 売上高(百万ドル) 1841.5
企業価値(EV) 企業価値(EV)(百万ドル) 4876.625
当期純利益 当期純利益(百万ドル) 160.70000
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Bruker Corporation revenues increased 9% to $875.4M. Net income increased 29% to $58.2M. Revenues reflect Bruker Scientific Instruments segment increase of 11% to $789.4M. Net income benefited from Bruker Scientific Instruments segment income increase of 21% to $82.9M Bruker Energy_Supercon Technologies segment income increase of 56% to $3.9M Eliminations segment income totaling $100K vs. $0K.

 BRKRのテクニカル分析


 BRKRのニュース

   Bruker Corporation 2022 Q1 - Results - Earnings Call Presentation  2022/05/04 12:18:05 Seeking Alpha
The following slide deck was published by Bruker Corporation in conjunction with their 2022 Q1 earnings call.
   Bruker Non-GAAP EPS of $0.49 beats by $0.07, revenue of $595M beats by $22.5M  2022/05/04 11:29:03 Seeking Alpha
Bruker press release (BRKR): Q1 Non-GAAP EPS of $0.49 beats by $0.07.Revenue of $595M (+7.3% Y/Y) beats by $22.5M.Shares +1.5% PM.
   Bruker Reports First Quarter Financial Results  2022/05/04 11:00:00 Business Wire
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced financial results for its first quarter ended March 31, 2022. First Quarter 2022 Financial Results Bruker’s revenues for the first quarter of 2022 were $595.0 million, an increase of 7.3% compared to $554.7 million in the first quarter of 2021. In the first quarter of 2022, revenues increased 10.5% organically year-over-year. Growth from acquisitions was 1.0%, while foreign currency transactions had a negative
   Bruker Q1 2022 Earnings Preview  2022/05/03 16:07:57 Seeking Alpha
Bruker (BRKR) is scheduled to announce Q1 earnings results on Wednesday, May 4th, before market open.The consensus EPS Estimate is $0.42 (-4.5% Y/Y) and the consensus Revenue Estimate…
   Bruker Demonstrates Novel and Unique Compact 1.0 GHz NMR Magnet  2022/04/25 11:00:00 Kwhen Finance
   Bruker Demonstrates Novel and Unique Compact 1.0 GHz NMR Magnet  2022/04/25 11:00:00 Kwhen Finance
   Bruker launches tests for detecting mycobacteria, sexually transmitted infections  2022/04/22 11:41:59 Seeking Alpha
Bruker (BRKR) said it launched new multiplex PCR infectious disease tests that are based on its LiquidArray technology
   Bruker Launches Unique LiquidArray® Multiplex PCR Assays  2022/04/22 11:00:00 Business Wire
LISBON, Portugal--(BUSINESS WIRE)---- $BRKR #BRKR--At the 32nd European Congress of Clinical Microbiology & Infectious Diseases (www.eccmid.org), Bruker Corporation (Nasdaq: BRKR) announces further advances in its market-leading MALDI Biotyper® (MBT) platform, and launches new multiplex PCR infectious disease assays that are based on its proprietary LiquidArray® technology. Bruker further expands its mycobacteria portfolio with the FluoroType® Mycobacteria PCR assay, launched on the high-precision FluoroCy
   Bruker Launches Unique LiquidArray Multiplex PCR Assays  2022/04/22 11:00:00 Wallstreet:Online
At the 32nd European Congress of Clinical Microbiology & Infectious Diseases (www.eccmid.org), Bruker Corporation (Nasdaq: BRKR) announces further advances in its market-leading MALDI Biotyper (MBT) platform, and launches new multiplex PCR infectious disease assays that are based on its proprietary LiquidArray technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220422005065/en/
   Bruker Announces Date and Time of First Quarter 2022 Earnings Release and Webcast  2022/04/18 20:05:00 Business Wire
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced it will report first quarter 2022 financial results before market opening on Wednesday, May 4, 2022. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current business trends. To listen to the webcast, investors can go to https://ir.bruker.com and click on the “Q1 2022 Earnings Webcast” hyperlink in the “Events & Presentations” section. A slide presenta
   Blood Culture Tests Market Has Ultimately Become Competitive with New Entrants, Insights on Players -Bruker Corporation, IRIDICA, T2 Biosystems .  2021/09/01 11:38:57 OpenPR
New York, United States: The experts at Decisive Markets Insights have broadcasted a report on the Blood Culture Tests MARKET that comprehensively inculcates a wide range of market products and their efficiency in promoting market growth worldwide. We assure you
   Global Atomic Spectroscopy Market (2021 to 2025) - Featuring Agilent Technologies, Aurora Biomed and Bruker Among Others  2021/09/01 10:18:00 Intrado Digital Media
Dublin, Sept. 01, 2021 (GLOBE NEWSWIRE) -- The "Global Atomic Spectroscopy Market 2021-2025" report has been added to ResearchAndMarkets.com''s offering. The publisher has been monitoring the atomic spectroscopy market and it is poised to grow by $2.79 bn during 2021-2025, progressing at a CAGR of almost 8% during the forecast period. Our report on the atomic spectroscopy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increased funding by government organizations for environmental testing and product safety and the rapid growth of end-user industries. The atomic spectroscopy market analysis includes the application segment and geographic landscape. This study identifies the rising awareness among end-users towards advanced instruments as one of the prime reasons driving the atomic spectroscopy market growth during the next few years.
   Circular Dichroism (CD) Spectrometers Market Key Insights, Profiling Companies and Growth Strategies  2021/09/01 03:16:31 OpenPR
The global circular dichroism (CD) spectrometer market is anticipated to grow due to presence of several regional and international players. Some of the major companies operating in the market are Applied Photophysics Ltd., Jasco, Bio-Logic Science Instrument, Inc., Bruker, and
   Bruker Corporation to Participate in the 2021 Wells Fargo Virtual Healthcare Conference  2021/08/30 20:10:00 Business Wire
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 2021 Wells Fargo Virtual Healthcare Conference. Gerald Herman, Executive Vice President & Chief Financial Officer, and Falko Busse, President of the Bruker BioSpin Group, will participate in an analyst moderated question and answer session on behalf of the Company on Friday, September 10, 2021 at 9:20 AM Eastern Time. A live audio webcast of the question and answer session will be
   CBRNE Detection Technologies Market Growth (Status and Outlook) 2021-2026: Argon Electronics , Blucher GmbH , Bruker , FLIR Systems , HDT Global  2021/08/26 18:54:58 Jumbo News
CBRNE Detection Technologies Market analysis report is sure to help boost sales and improve return on investment (ROI). The research and analysis carried out in this CBRNE Detection Technologies Market report assists clients to forecast investment in an emerging market, expansion of market share or success of a new product with the help of global []

 関連キーワード  (先端医療機器_テクノロジ― 米国株 ブルカ― BRKR Bruker Corporation)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)